Industry News
Nox Health, a global sleep health leader in sleep diagnostics and value-based sleep care management, recently announced that it has closed the acquisition of Somryst, the first and only FDA-approved prescription digital therapeutic that delivers effective, first-line treatment for adults with chronic insomnia.
Industry News
Nox Health has joined the American Heart Association Center for Health Technology & Innovations Innovators’ Network, a center focused on fostering health technology relationships to develop innovative and scalable solutions.
Company Updates
Nox Health, the global sleep health leader and parent company of Nox Medical, announced today a strategic growth investment from Vestar Capital Partners, a leading middle-market private equity firm in the United States. The investment will help Nox accelerate development…
